Europe

ReCor Medical announced randomization of its 146th, and final, subject in the SOLO cohort of its RADIANCE-HTN study. RADIANCE-HTN, ReCor's...

Aptar Pharma, a leading drug delivery systems provider, will once again bea key exhibitor at Pharmapack 2018, Europe's dedicated pharmaceutical...

GSK welcomes the launch of the UK Government’s Life Sciences Sector Deal, which builds on the Industrial Strategy published by...

Canon BioMedical is pleased to announce our latest geographic expansion into the German-speaking countries of Austria, Germany, and Switzerland. We...

Sanofi's Toujeo met the primary study objective in the first large head-to-head clinical trial, called BRIGHT study, comparing Toujeo with...

The European Medicines Agency (EMA) has accepted to review Mylan’s marketing authorisation applications (MAA) for proposed biosimilar trastuzumab and proposed...

Merck, known as MSD outside the United States and Canada, announced that new and updated data from six abstracts investigating...

Use of Sanofi’s dengue vaccine, the world’s first approved shot against the mosquito-borne virus, is to be strictly limited due...

AstraZeneca today announced that the EMA has accepted a variation to the Marketing Authorisation Application (MAAv) for Tagrisso (osimertinib), a...

Novartis announced positive results from the FLASH study examining the safety and efficacy of directly switching chronic obstructive pulmonary disease...